Rapt Therapeutics (RAPT)
(Delayed Data from NSDQ)
$1.76 USD
0.00 (0.00%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $1.77 +0.01 (0.57%) 4:44 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Rapt Therapeutics (RAPT) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$8.00 | $17.00 | $2.00 | 354.55% |
Price Target
Based on short-term price targets offered by six analysts, the average price target for Rapt Therapeutics comes to $8.00. The forecasts range from a low of $2.00 to a high of $17.00. The average price target represents an increase of 354.55% from the last closing price of $1.76.
Analyst Price Targets (6 )
Broker Rating
Rapt Therapeutics currently has an average brokerage recommendation (ABR) of 2.33 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 12 brokerage firms. The current ABR compares to an ABR of 2.33 a month ago based on 12 recommendations.
Of the 12 recommendations deriving the current ABR, four are Strong Buy, representing 33.33% of all recommendations. A month ago, Strong Buy represented 33.33%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 4 | 4 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 8 | 8 | 8 | 8 | 8 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.33 | 2.33 | 2.33 | 2.33 | 2.33 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/6/2024 | UBS | Eliana Merle | Hold | Hold |
8/16/2024 | SVB Securities | Thomas J Smith | Hold | Hold |
8/14/2024 | Guggenheim Securities | Yatin Suneja | Hold | Hold |
8/13/2024 | Piper Sandler | Edward A Tenthoff | Strong Buy | Strong Buy |
8/9/2024 | Wells Fargo Securities | Yanan Zhu | Strong Buy | Strong Buy |
8/9/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
7/23/2024 | H.C. Wainwright & Co. | Raghuram Selvaraju | Hold | Hold |
5/14/2024 | Not Identified | Not Identified | Strong Buy | Hold |
5/10/2024 | Not Identified | Not Identified | Strong Buy | Hold |
2/20/2024 | Cantor Fitzgerald & Co | Prakhar Agrawal | Strong Buy | Hold |
2/16/2024 | Evercore Partners | Umer Raffat | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.33 |
ABR (Last week) | 2.33 |
# of Recs in ABR | 12 |
Average Target Price | $8.00 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 82 of 253 |
Current Quarter EPS Est: | -0.56 |
RAPT FAQs
Rapt Therapeutics (RAPT) currently has an average brokerage recommendation (ABR) of 2.33 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 12 brokerage firms.
The average price target for Rapt Therapeutics (RAPT) is $8.00. The current on short-term price targets is based on 6 reports.
The forecasts for Rapt Therapeutics (RAPT) range from a low of $2 to a high of $17. The average price target represents a increase of $354.55 from the last closing price of $1.76.
The current UPSIDE for Rapt Therapeutics (RAPT) is 354.55%
Based on short-term price targets offered by six analysts, the average price target for Rapt Therapeutics comes to $8.00. The forecasts range from a low of $2.00 to a high of $17.00. The average price target represents an increase of 354.55% from the last closing price of $1.76.